Siemens Healthineers AG (OTCMKTS:SMMNY) Shares Shorted: Short Interest Down 89.8% in October

Siemens Healthineers AG (OTCMKTS:SMMNY) was the recipient of a significant drop in short interest during the month of October. As of October 30th, there was short interest totaling 7,112 shares, a drop of 89.8% from the October 15th total of 69,756 shares. Based on an average trading volume of 66,210 shares, the days-to-cover ratio is presently 0.1 days.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on SMMNY shares. Citigroup restated a “buy” rating on shares of Siemens Healthineers in a research note on Tuesday, October 13th. Zacks Research downgraded shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 1st. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Siemens Healthineers in a report on Tuesday, August 18th. Finally, Royal Bank Of Canada reissued an “outperform” rating on shares of Siemens Healthineers in a research report on Friday, October 16th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Siemens Healthineers presently has an average rating of “Moderate Buy”.

Siemens Healthineers Stock Performance

OTCMKTS SMMNY traded up $0.01 on Wednesday, reaching $24.09. The stock had a trading volume of 10,084 shares, compared to its average volume of 125,778. Siemens Healthineers has a 1-year low of $19.20 and a 1-year high of $27.46. The firm has a fifty day moving average of $22.64 and a two-hundred day moving average of $21.93.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a Germany-based medical technology company that develops products, services and digital solutions for healthcare providers. Its portfolio supports diagnostic, therapeutic and monitoring activities across hospitals, clinics, laboratories and other healthcare settings. The company’s offerings include magnetic resonance imaging, computed tomography, X-ray, molecular imaging and ultrasound systems, as well as laboratory diagnostics, point-of-care testing and related software.